LL
Lawley Lori D
Chief Financial Officer
OtherF
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lawley Lori D, Chief Financial Officer. Officer active across 2 companies, notably LUMOS PHARMA, INC.. Aggregated, 13 filings have been published. History available since 1 August 2021. The latest transaction was disclosed on 1 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
12,284 sharesCommon StockSEC:0001126234-24-000112:0
229 shares@ US$1.791.8% of flowCommon StockSEC:0001126234-24-000092:0
1,000 shares@ US$2.8412.4% of flowCommon StockSEC:0001126234-24-000038:0
215 shares@ US$3.012.8% of flowCommon StockSEC:0001126234-24-000014:0
229 shares@ US$3.283.2% of flowCommon StockSEC:0001126234-23-000084:0
274 shares@ US$3.313.9% of flowCommon StockSEC:0001126234-23-000050:0
1,000 shares@ US$3.5215.1% of flowCommon StockSEC:0001126234-23-000015:0
229 shares@ US$8.178.5% of flowCommon StockSEC:0001126234-22-000071:0
274 shares@ US$9.2320.4% of flowCommon StockSEC:0001126234-22-000033:0
1,000 shares@ US$10.0279.6% of flowCommon StockSEC:0001126234-22-000009:0
1,000 shares@ US$10.02100.0% of flowCommon StockSEC:0001126234-22-000009
3,750 shares0Common StockSEC:0001126234-21-000101:0
3,750 shares0Common StockSEC:0001126234-21-000101
About Lawley Lori D
Lawley Lori D serves as Chief Financial Officer at Lumos Pharma, Inc. She is responsible for the company's financial management, including financial planning, risk management, and regulatory compliance. Her financial expertise is crucial for supporting the company's growth and sustainability.